These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. Brugnara C, de Franceschi L, Alper SL. J Clin Invest; 1993 Jul 01; 92(1):520-6. PubMed ID: 8326017 [Abstract] [Full Text] [Related]
9. Prevention of red cell dehydration: a possible new treatment for sickle cell disease. Mueller BU, Brugnara C. Pediatr Pathol Mol Med; 2001 Jul 01; 20(1):15-25. PubMed ID: 12673842 [Abstract] [Full Text] [Related]
10. Combined genetic disruption of K-Cl cotransporters and Gardos channel KCNN4 rescues erythrocyte dehydration in the SAD mouse model of sickle cell disease. Shmukler BE, Rivera A, Bhargava P, Nishimura K, Hsu A, Kim EH, Trudel M, Rust MB, Hubner CA, Brugnara C, Alper SL. Blood Cells Mol Dis; 2019 Nov 01; 79():102346. PubMed ID: 31352162 [Abstract] [Full Text] [Related]
12. Modulation of erythrocyte potassium chloride cotransport, potassium content, and density by dietary magnesium intake in transgenic SAD mouse. De Franceschi L, Beuzard Y, Jouault H, Brugnara C. Blood; 1996 Oct 01; 88(7):2738-44. PubMed ID: 8839870 [Abstract] [Full Text] [Related]
13. A new therapeutic approach for sickle cell disease. Blockade of the red cell Ca(2+)-activated K+ channel by clotrimazole. Brugnara C, De Franceschi L, Armsby CC, Saadane N, Trudel M, Beuzard Y, Rittenhouse A, Rifai N, Platt O, Alper SL. Ann N Y Acad Sci; 1995 Jul 12; 763():262-71. PubMed ID: 7677336 [No Abstract] [Full Text] [Related]
15. Treatment with NS3623, a novel Cl-conductance blocker, ameliorates erythrocyte dehydration in transgenic SAD mice: a possible new therapeutic approach for sickle cell disease. Bennekou P, de Franceschi L, Pedersen O, Lian L, Asakura T, Evans G, Brugnara C, Christophersen P. Blood; 2001 Mar 01; 97(5):1451-7. PubMed ID: 11222393 [Abstract] [Full Text] [Related]
17. [Clinical trials of new therapeutic pharmacology for sickle cell disease]. Brugnara C, de Franceschi L. Sante; 2006 Mar 01; 16(4):263-8. PubMed ID: 17446160 [Abstract] [Full Text] [Related]
18. Effect of 1-chloro-2,4-dinitrobenzene on K+ transport in normal and sickle human red blood cells. Muzyamba MC, Gibson JS. J Physiol; 2003 Mar 15; 547(Pt 3):903-11. PubMed ID: 12576491 [Abstract] [Full Text] [Related]